DHFR and colonic neoplasm: Deletion of G6PD resulted in high NADP+, leading to dihydrofolate reductase (DHFR) inhibition, and ultimately, impairment of folate-mediated biosynthesis in colon cancer cells, unveiling an important connection between NADPH and folate metabolism [41].